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A B S T R A C T
Terminal-stage patients on peritoneal dialysis (PD) are often transferred to haemodialysis 
as they are unable to perform the dialysis technique themselves since their functional 
capacities are reduced. We present our experience with five patients on PD with a short-
term life-threatening condition, whose treatment was shared by primary care units and who 
were treated with a PD modality adapted to their circumstances, which we call Palliative 
Peritoneal Dialysis.
© 2015 Sociedad Española de Nefrología. Published by ELSEVIER ESPAÑA, SLU. Published 
under the terms of the CC BY-NC-ND Licence(http://creativecommons.org/licenses/
by-nc-nd/4.0).
Diálisis peritoneal paliativa: implantación de un programa de atención 
domiciliaria a enfermos tratados con diálisis peritoneal (DP) en situación 
terminal
R E S U M E N
Los pacientes en Diálisis peritoneal (DP) en situación terminal suelen ser transferidos a 
hemodiálisis ya que son incapaces de realizarse la técnica dialítica a consecuencia de que 
sus capacidades funcionales están disminuidas. Presentamos nuestra experiencia con 5 
pacientes en DP con patología que amenazaba su vida a corto plazo, cuyo tratamiento fue 
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cases. The frequency of home visits and blood tests was estab-
lished by the PCP and adjusted to the needs of the patient. In 
this manner, no patient came back to the hospital PD Unit for 
a periodical medical follow-up.
The pharmacological treatment was adjusted to the needs 
and situation of the patient. As a general rule, all drugs were 
discontinued except for erythropoietin and antihypertensive 
drugs. Medication for symptoms treatment (analgesia, seda-
tives, etc.) was left at the discretion of the PCP. The physician 
of the long-term unit played the same role. There was fluent 
and permanent telephone contact between the PD Unit, care-
givers and primary care professionals until death. Below, we 
present the characteristics of the five patients that required 
palliative care in our PD Unit. In order to measure the degree 
of independence of the patients prior to requiring palliative 
care, we used the Barthel activities of daily living index. 
Results
Four men and one woman were included in this programme. 
Mean age was 49 (range: 46 to 67) and the Charlson index was 
11 ± 5.6 (range: 5 to 18). The underlying disease was: chronic 
glomerulonephritis (n = 2), radical nephrectomy due to bilat-
eral renal carcinoma (n = 1), diabetic nephropathy (n = 1) and 
undetermined kidney disease (n = 1). Three patients were HIV 
positive. Two patients lived alone before reaching the end-
stage condition. All were on manual PD technique and inde-
pendent for activities of daily living (Barthel index 50, 75, 85, 
60 and 65, respectively) and able to perform the dialysis tech-
nique themselves before experiencing the event that led to 
their admission to the palliative programme. Four patients 
were anuretic and the fifth patient had a diuresis of 200 mL/24 
h. After 42.6 ± 27 months (range: 16 to 81) on PD, they devel-
oped the following nonreversible complications: two cachexia, 
one hepatic carcinoma with frequent hospital admissions due 
to encephalopathy, one metastatic squamous cell carcinoma, 
and one invasive bilateral renal carcinoma relapse. Four 
patients were treated with family-assisted PD at home until 
their death, and one patient was treated in a public LSU. The 
survival was 17 to 119 days, with a mean of 33 days. Only one 
patient was admitted to the Hospital for three days after ini-
tiating palliative care. Assisted PD was manual in all the 
cases. One or two exchanges per day were scheduled, and in 
specific cases a third exchange was performed when it was 
necessary to guarantee ultrafiltration. Four patients were 
managed with 2.27% glucose and only one patient received 
icodextrin in the long exchange. The characteristics of the 
patients are detailed in Table I. 
Introduction
Terminal-stage patients on peritoneal dialysis (PD) whose 
pathology is life threatening in the short term have reduced 
functional capacities and serious difficulties in performing 
peritoneal exchanges or attending regular check-ups at the 
hospital. Under these circumstances, patients in the PD pro-
gramme are often transferred to haemodialysis (HD). However, 
since they are conscious of their end-stage condition, some 
patients who had opted for PD to maintain their personal inde-
pendence express their desire to die at home and remain on 
PD until the end. The current health care organisation in Spain 
does not offer this possibility. We present our experience with 
a home care programme for terminal patients on PD who are 
managed in collaboration with their primary care physician 
(PCP) and maintained on PD until their death.  
Patients and methods
Between May 1995 and December 2013, 307 patients with PD 
were treated by our Department, 5 of whom required pallia-
tive care due to an irreversible pathology with a short-term 
fatal prognosis. We analysed their data retrospectively from 
the PD Unit database. All the patients had expressed their 
desire to die at home, so it was necessary for them to remain 
on PD and not be transferred to HD. Making palliative care 
and PD compatible with the current functional structure of 
our Unit did not seem an easy task, although we wanted to 
meet all our patients’ wishes. 
Therefore, we contacted their PCP to ask him/her to share 
in the patients’ follow-up and dialysis technique. A primary 
care (PC) nurse underwent a short training course (one to 
three days) in the PD Unit. This was necessary because, while 
three of the patients lived with family members who were 
familiar with the technique, two patients lived alone. Besides, 
as the nurse was going to be their closest contact, we believed 
it was convenient for him/her to learn the technique in order 
to inspire higher confidence in the patient and family mem-
bers. We also trained a member of the ancillary staff of a 
public Long-Stay Unit (LSU) for chronic patients. This staff 
member trained the other members of the unit, where one 
patient was admitted until his death. 
The primary care staff drew blood samples for lab tests at 
the patients’ homes, and the results were reported to us by 
phone along with clinical patient information. Blood tests 
included haemogram and basic blood chemistry. No urinaly-
sis, Kt/V or PET measurements were ordered in any of the 
compartido por las unidades de atención primaria y fueron mantenidos en una modalidad 
de DP adaptada a sus circunstancias a la que hemos denominado Diálisis Peritoneal Paliativa.
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family members who were trained in the technique, but he 
needed an individualised treatment, at home if possible, for 
the tumour-related symptoms. Given this circumstance and 
wishing to respect this request, we opted to contact the 
patient’s PCP. After explaining the situation, we asked the 
physician to share in the responsibility of monitoring the 
patient and dialysis technique with us. This request was 
immediately accepted. Our nursing staff gave the visiting 
nurse a short training session on the PD technique. This 
patient died 20 days later, without requiring office visits or 
hospital admission. We have repeated the experience four 
more times. In each case, both the patients and families have 
personally manifested their satisfaction to us, while we our-
selves have also felt satisfied. We must highlight that patient 
No. 3 was admitted to a publicly-funded LSU and treated with 
PD until the moment of death 119 days later. In this case, a 
member of the LSU ancillary staff was trained at our PD Unit 
and was later able to teach the LSU staff. 
Since 1990, the Community of Madrid has progressively 
implemented a health care resource directed at providing 
palliative care services for both Specialised Care and Primary 
Care. Family members of treated patients and the participat-
ing staff themselves have shown a high rate of satisfaction 
with this high-quality care11. In 1991 and 1992, Health Areas 
4 and 11 initiated specific programmes directed towards ter-
minal patients that were based on the collaboration between 
Primary and Specialized Care in order to ensure continuous 
care. In addition, six home care support teams12 were created 
in 1999, under the management of Primary Care, in order to 
collaborate with and support PCP when treating immobilised 
terminal-stage patients. Subsequently, Act 16/2003 (from May 
28th) on the Cohesion and Quality of the National Health Care 
Service specifically included palliative care for terminal 
patients, both in Primary Care and Specialised Care services. 
The health area of Ramón y Cajal Hospital and Gregorio 
Marañón Hospital was a pioneer in the implementation of 
specialised and continuous care programmes for terminal 
patients based on the collaboration and coordination between 
Primary Care and Specialised Care. These programmes are 
aimed at any and all patients at a terminal stage, including 
renal patients. In its 2004 report, the ESAD (Equipo de Soporte 
de Atención Domiciliaria [Home Care Support Team]) of the 
Community of Madrid assisted 24 terminal nephrology 
patients, as detailed in its report11.
Assisted peritoneal dialysis, performed by either qualified 
staff or a family member, is a good solution for patients on PD 
at a terminal stage without the need to transfer them to HD13. 
Discussion
Palliative Care Units (PCU), which have traditionally focused 
on patients with terminal-stage cancer, have had to widen 
their field of action in recent years due to the increasing 
demand for assistance and palliative support by patients with 
chronic, progressive non-cancer pathologies.1-3
At the beginning of the 21st century, palliative care 
extended to include other pathologies, such as chronic kidney 
disease, with the intention of humanising and easing the 
transition to death, not only for patients but also for their 
family members4,5. Thus, in recent years there has been a 
growing interest within the nephrology community to offer 
palliative care to patients with chronic kidney disease. This 
is either because they are not eligible for dialysis and would 
therefore start conservative treatment, or because discontin-
uation of dialysis treatment is considered the best option. In 
this regard, there are several excellent publications where the 
need for multidisciplinary palliative care units for renal 
patients was justified and the grounds were set forth, not only 
in Spain but also worldwide6,7,8.
But, what if the patient is eligible for palliative care and 
does not want to discontinue dialysis? The decision to discon-
tinue dialysis raises concerns. It is perceived as suicide in up 
to 12% of patients9, and it may even be considered euthanasia 
from a family standpoint. This dilemma is partially solved 
through the new “palliative dialysis” concept10, which basi-
cally involves continuing dialysis treatment but replacing the 
usual targets of dialysis efficiency (Kt/V, dry weight, PTH lev-
els, etc.) with asymptomatic patient targets. Thus, palliative 
dialysis consists in individualising the dialysis prescription 
for each patient, focusing on ultrafiltration rather than on the 
clearance of uraemic solutes. The palliative dialysis men-
tioned in the literature is, in fact, palliative HD, and patients 
on PD who may require palliative care would be transferred 
to HD when they are not independent enough to make 
exchanges themselves.
Moreover, what if patients on PD who require palliative 
care do not want to change their dialysis technique? That is 
to say, if patients have chosen home dialysis and express the 
explicit desire to continue said treatment when facing the end 
of life, should we keep them on PD or transfer them to HD? 
This is the situation of our patients. The first time we faced 
this event was in 2001. As mentioned above, our patient had 
a highly invasive bilateral renal carcinoma recurrence with a 
poor short-term prognosis. The patient had the support of 
Table I – 
Pat. Age Sex Terminal  
Pathology







1 67 H Kidney Cancer 5 20 0 0 wife 2001
2 49 M Cachexia 115 39 0 0 daughter 2007
3 53 H Metastatic Cancer 40 119 0 200 LSU 2010
4 48 H Liver Cancer 40 33 3 100 parents 2011
5 46 H Cachexia 113 17 0 0 aunt 2013
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The traditional model of assisted PD is based on using a cycler 
at night with a dry day, which makes the dialysis technique 
compatible with the daily life of the caregiver and avoids over-
burdening him/her. This modality was not applied in our 
patients since all of them received manual PD treatment and 
there was no training with cyclers. What we propose for ter-
minal patients on PD is, in fact, Palliative Peritoneal Dialysis, 
which we define as PD therapy that, on the one hand, can 
keep the patient free of symptoms such as dyspnoea and, on 
the other hand, makes the patient feel cared for (dialysed) 
until the end, without overwhelming the main caregiver. 
In our experience, this has been possible through manual 
peritoneal dialysis with 1 or 2 glucose exchanges every 24 
hours. In patients in whom blood volume control is a priority, 
a long icodextrin day exchange combined with a glucose night 
exchange could be the recommended pattern. 
To summarise, PD may be continued until the end of life 
of patients at a terminal stage, without transferring them to 
HD and without overburdening the caregiver. In our experi-
ence, the support of primary care professionals was essential 
to provide these patients with proper, individualised treat-
ment and to comply with the Patient Autonomy Law14. 
Selfless support provided by the primary care staff allowed 
patients to continue PD treatment and to receive home care 
without the need to be transferred to HD, thus respecting 
their desire to die at home. Assisted Palliative PD is well 
accepted by family members and does not involve a severe 
burden during the short survival of said patients. Decision-
making in patients with an end-stage condition must be 
shared, while taking into consideration the patient’s clinical 
situation, prognosis, quality of life and desires. In cases where 
PD discontinuation may increase the anxiety and distress of 
the patient and family, we believe that palliative peritoneal 
dialysis is a good solution.
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